"Cardiovascular Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
Descriptor ID |
D002318
|
MeSH Number(s) |
C14
|
Concept/Terms |
Cardiovascular Diseases- Cardiovascular Diseases
- Cardiovascular Disease
- Disease, Cardiovascular
- Diseases, Cardiovascular
|
Below are MeSH descriptors whose meaning is more general than "Cardiovascular Diseases".
Below are MeSH descriptors whose meaning is more specific than "Cardiovascular Diseases".
This graph shows the total number of publications written about "Cardiovascular Diseases" by people in this website by year, and whether "Cardiovascular Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 3 | 0 | 3 |
1996 | 4 | 1 | 5 |
1997 | 7 | 0 | 7 |
1998 | 1 | 2 | 3 |
1999 | 3 | 3 | 6 |
2000 | 6 | 1 | 7 |
2001 | 1 | 1 | 2 |
2002 | 4 | 2 | 6 |
2003 | 6 | 6 | 12 |
2004 | 22 | 8 | 30 |
2005 | 12 | 8 | 20 |
2006 | 27 | 7 | 34 |
2007 | 29 | 6 | 35 |
2008 | 22 | 5 | 27 |
2009 | 25 | 11 | 36 |
2010 | 22 | 9 | 31 |
2011 | 33 | 12 | 45 |
2012 | 32 | 19 | 51 |
2013 | 39 | 13 | 52 |
2014 | 49 | 15 | 64 |
2015 | 43 | 10 | 53 |
2016 | 65 | 12 | 77 |
2017 | 37 | 12 | 49 |
2018 | 64 | 10 | 74 |
2019 | 66 | 10 | 76 |
2020 | 72 | 8 | 80 |
2021 | 74 | 10 | 84 |
2022 | 86 | 1 | 87 |
2023 | 84 | 3 | 87 |
2024 | 59 | 13 | 72 |
2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cardiovascular Diseases" by people in Profiles.
-
Cardiovascular Disease and Breast Cancer Stage at Diagnosis. JAMA Netw Open. 2025 Jan 02; 8(1):e2452890.
-
The role of the triglyceride-glucose index as a biomarker of cardio-metabolic syndromes. Lipids Health Dis. 2024 Dec 23; 23(1):416.
-
Trends in Cardiovascular Disease-Related Mortality in Texas. Tex Heart Inst J. 2024 Jul-Dec; 51(2):e248426.
-
Palbociclib plus aromatase inhibitors in patients with metastatic breast cancer and cardiovascular diseases: real-world effectiveness. Oncologist. 2024 Dec 06; 29(12):1032-1043.
-
Highlights of Cardiovascular Disease Prevention Studies?Presented at the 2024 European Society of Cardiology?Congress. Curr Atheroscler Rep. 2024 Dec 02; 27(1):14.
-
Interplay of Reactive Oxygen Species (ROS) and Epigenetic Remodelling in Cardiovascular Diseases Pathogenesis: A Contemporary Perspective. Front Biosci (Landmark Ed). 2024 Nov 21; 29(11):398.
-
Racial and Ethnic Disparities in Perceived Health Status Among Patients With Cardiovascular Disease. Prev Chronic Dis. 2024 Nov 14; 21:E89.
-
Cardiovascular Risk Factors and Genetic Risk in Transthyretin V142I Carriers. JACC Heart Fail. 2025 Jan; 13(1):91-101.
-
A Costly Cure: Understanding and Addressing Financial Toxicity in Cardiovascular Disease Health Care Within the Domain of Social Determinants of Health. Methodist Debakey Cardiovasc J. 2024; 20(5):15-26.
-
Protein Consumption and Risk of CVD Among U.S. Adults: The Multi-Ethnic Study of Atherosclerosis (MESA). Nutrients. 2024 Nov 02; 16(21).